Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

E-ISSN： 1873-4286|20|39|6096-6105

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.39, 2014-12, pp. : 6096-6105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Anticoagulants for Stroke Prophylaxis in Atrial Fibrillation: Assessing the Impact on Medication Adherence

By Kopecky Stephen

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim Schott Gisela

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Anticoagulants, renal failure and atrial fibrillation

By Genovesi Simonetta

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Atrial fibrillation – all change!

By Savelieva Irina Camm John

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 374-379

Royal College Of Physicians

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi Elming Hanne Pedersen Ole Dyg Torp-Pedersen Christian

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite